Jun Yao Health announced that the daily closing price increase deviation value of the company's stock exceeded 20% for 3 consecutive trading days on September 28, September 29, and September 30, 2026, constituting abnormal fluctuations in stock trading. After verification, the company's production and operation are normal, there have been no major adjustments to the market environment or industry policies, and there are no major matters or media reports or market rumors that should be disclosed but not disclosed. The company's net profit attributable to shareholders of listed companies for the first half year of 2026 was 4.491 million yuan, a decrease of 39.74% over the same period last year.

Jun Yao Health announced that the daily closing price increase deviation value of the company's stock exceeded 20% for 3 consecutive trading days on September 28, September 29, and September 30, 2026, constituting abnormal fluctuations in stock trading. After verification, the company's production and operation are normal, there have been no major adjustments to the market environment or industry policies, and there are no major matters or media reports or market rumors that should be disclosed but not disclosed. The company's net profit attributable to shareholders of listed companies for the first half year of 2026 was 4.491 million yuan, a decrease of 39.74% over the same period last year.